Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
As of March 2025 65.99% is owned by Indian Promoters and 34.01% by Public. Top four Promoters holding highest number of shares of Balaxi Pharmaceutic...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Windowmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tradi...more...
BALAXI PHARMACEUTICALS LIMITED has submitted the Exchange a copy Srutinizers report of Postal Ballot along with Voting Resultsmore...
Significant movement in price has been observed in BALAXI PHARMACEUTICALS LIMITED. The Exchange in order to ensure that investors have lates...more...
Significant movement in price has been observed in BALAXI PHARMACEUTICALS LIMITED. The Exchange in order to ensure that investors have latest relevan...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Submission of the unaudited financial results for the quarter and nine mo...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publicationmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballotmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Notice of Postal Ballotmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentationmore...
Integrated Filing (Financial)more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32more...
The company reported standalone net profit of Rs 1.74 crore for the quarter ended December 31 2024 as compared to Rs 0.49 crore in the same ...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Board Comments on fine levied by the exchange .more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding outcome of Board meeting held on February 10 2025.more...
BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange the financial results for the period ended December 31 2024.more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2025 to consider and approve the Quarterly...more...
Enter Stock
BOARD MEETINGS Company Name : Ascensive Educare Date : 05-05-2025